U.S., April 4 -- ClinicalTrials.gov registry received information related to the study (NCT06908577) titled 'An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab' on April 02.
Brief Summary: The purpose of this study is to compare the pharmacokinetic (PK) exposures of a single subcutaneous (SC) dose of tozorakimab administered using AI or APFS in healthy participants.
Study Start Date: April 07
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Tozorakimab
Tozorakimab will be administered as a single SC dose using an AI or APFS device on Day 1.
DEVICE: Autoinjector (AI) Device
AI device will be used to administer single SC dose of tozorakimab on Day 1.
DEVI...